|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
4/25/2007 10:32:25 AM
SCOTTSDALE, AZ -- (MARKET WIRE) -- April 24, 2007 -- IR BioSciences Holdings, Inc. (OTCBB: IRBO) announced today that it has appointed Robert J. Hariri, M.D., Ph.D. to its Board of Directors. Dr. Hariri is the Chief Executive Officer, of Celgene Cellular Therapeutics, a division of Celgene Corp., a world leader in human cellular and tissue therapeutics and a company with a market capitalization of more than $21 Billion. Dr. Hariri is a highly successful entrepreneur, has extensive experience in the capital markets and in developing start-up companies into highly successful commercial operations. He also has been extensively published in leading medical and scientific publications. This year he was named the National Multiple Sclerosis Pharmaceutical Executive of the Year. Last year, he was the recipient of the Thomas Alva Edison Patent Award. He has also received many other awards for his medical and entrepreneurial accomplishments.
|
|
|
|
|
|
|
|
|
|
|